FindTrial
Sign In

Management of severe facial pain using nerve block technique.

Feasibility and efficacy of ultrasound-guided trigeminal nerve block via pterygopalatine fossa for the management of refractory idiopathic trigeminal neuralgia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/01/017154
Enrollment
40
Registered
2019-01-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G518- Other disorders of facial nerve

Interventions

Intervention1: Trigeminal nerve block: Injection of 4 mL of bupivacaine 0.25%, and 40 mg of triamcinolone on the side of the face just below the zygomatic bone in the pterygopalatine fossa using ultr

Sponsors

PGIMER Chandigarh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 40 consecutive adult patients of idiopathic trigeminal neuralgia resistant to pharmacological treatment will be included

Exclusion criteria

Exclusion criteria: Allergy to local anesthetics or steroids, infection, coagulopathy, and pregnancy.

Design outcomes

Primary

MeasureTime frame
Patients will be asked to rate their 24-hour global pain experience including severity, duration, frequency of the episodes, and to report it as a percentage of global pain reliefTimepoint: at 2 weeks, 1 month, 2 month and 3 months after procedure—

Secondary

MeasureTime frame
Duration of procedure, complications and success rateTimepoint: during and after the procedure and at 1, 2 and 3 months—

Countries

India

Contacts

Public ContactDr Neerja Bharti

PGIMER

bhartineerja@yahoo.com9915575145

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026